{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-25-year-minimum-archiving-and-sponsor-responsibility”
},
“headline”: “SOP for 25-Year Minimum Archiving and Sponsor Responsibility”,
“description”: “This SOP outlines procedures for ensuring compliance with EMA and EU CTR requirements on minimum 25-year archiving of clinical trial records. It defines sponsor responsibilities, secure storage standards, premature destruction prevention, and inspection readiness obligations.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for 25-Year Minimum Archiving and Sponsor Responsibility

Purpose

The purpose of this SOP is to define requirements and processes for archiving essential clinical trial records for a minimum of 25 years, in compliance with the EU Clinical Trials Regulation (EU CTR 536/2014) and EMA guidance. This SOP ensures sponsor accountability for secure, long-term storage of both paper and electronic records.

Scope

This SOP applies to sponsors, CROs, investigators, and QA personnel involved in archiving of trial master files (TMFs), investigator site files (ISFs), safety records, and essential clinical trial documents. It covers responsibilities, archiving standards, premature destruction prevention, and regulatory inspection readiness.

Responsibilities

• Sponsor: Ensures compliance with 25-year archiving, oversees CROs and sites, and funds secure long-term storage.
• Investigator: Maintains investigator site records and ensures transfer to secure archives.
• CRO: Supports sponsor in TMF/ISF maintenance and vendor oversight.
• QA: Audits archive facilities and processes to ensure compliance.
• Archive Vendor: Provides validated storage with environmental and security controls.

Accountability

The Sponsor is ultimately accountable for 25-year record retention compliance, regardless of delegation to CROs or archive vendors.

Procedure

1. Identification of Essential Records
1.1 Identify documents required for 25-year retention under EU CTR.
1.2 Include TMF, ISF, safety reports, informed consent forms, and regulatory correspondence.
1.3 Record in Essential Documents List (Annexure-1).

2. Secure Archiving
2.1 Store documents in validated archive facilities with environmental monitoring (temperature, humidity).
2.2 Maintain access logs.
2.3 Record in Archive Facility Log (Annexure-2).

3. Electronic Records
3.1 Validate electronic archiving systems with audit trails.
3.2 Perform periodic data integrity checks.
3.3 Record in Electronic Archive Log (Annexure-3).

4. Prevention of Premature Destruction
4.1 Records must not be destroyed before 25 years unless authorized by EMA.
4.2 Maintain Destruction Prevention Log (Annexure-4).

5. Access and Confidentiality
5.1 Limit access to authorized staff only.
5.2 Document in Archive Access Log (Annexure-5).

6. Inspection Readiness
6.1 Maintain archives in inspection-ready condition.
6.2 Conduct periodic mock audits recorded in Archive Audit Log (Annexure-6).

Abbreviations

• SOP: Standard Operating Procedure
• TMF: Trial Master File
• ISF: Investigator Site File
• EMA: European Medicines Agency
• EU CTR: European Union Clinical Trials Regulation
• CRO: Contract Research Organization
• QA: Quality Assurance

Documents

1. Essential Documents List (Annexure-1)
2. Archive Facility Log (Annexure-2)
3. Electronic Archive Log (Annexure-3)
4. Destruction Prevention Log (Annexure-4)
5. Archive Access Log (Annexure-5)
6. Archive Audit Log (Annexure-6)

References

• EU Clinical Trials Regulation (EU CTR 536/2014)
• European Medicines Agency (EMA)
• ICH GCP E6(R2)

Version: 1.0

Approval Section

Annexures

Annexure-1: Essential Documents List

Annexure-2: Archive Facility Log

Annexure-3: Electronic Archive Log

Annexure-4: Destruction Prevention Log

Annexure-5: Archive Access Log

Annexure-6: Archive Audit Log

Revision History

For more SOPs visit: Pharma SOP